Aclaris Therapeutics (ACRS) Return on Sales [ROS] (2017 - 2026)
Aclaris Therapeutics' Return on Sales [ROS] came in at -1487.91% for Q2 2026, down 452.00 percentage points from -1035.90% a year earlier and down 376.08 percentage points from the prior quarter.
Aclaris Therapeutics (ACRS) Return on Sales [ROS] (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Aclaris Therapeutics reported Return on Sales [ROS] of -1050.16%, down 176.75 percentage points year-over-year; for FY2025, it came in at -975.91%, down 217.73 percentage points from FY2024.
- Return on Sales [ROS] has declined in each of the last three years, with a five-year change of -190.48 percentage points (FY2020 to FY2025).
- Going back by year, Return on Sales [ROS] was -758.18% in FY2024 (-446.63 pp), -311.55% in FY2023 (-9.54 pp), -302.01% in FY2022 (+1025.06 pp) and -1327.07% in FY2021 (-541.63 pp).
- The five-year range for quarterly Return on Sales [ROS] is -1755.52% (Q4 2025) to -23.03% (Q4 2023).
- Year-over-year, Return on Sales [ROS] increased in two of the last eight quarters, with an average year-over-year change of -407.21 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q2 2024 (a gain of 1237.53 percentage points), and the weakest in Q4 2024 (a drop of 1059.10 percentage points).
- Business Quant data shows ACRS's Return on Sales [ROS] at -1111.82% (Q1 2026), -1755.52% (Q4 2025) and -519.82% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Aclaris Therapeutics | 625.92 Mn | 223.91 Mn | 1.29 Mn | -1,441.19% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1,441.19% |
| Jun 30, 2026 | -1,487.91% |
| Mar 31, 2026 | -1,111.82% |
| Dec 31, 2025 | -1,755.52% |
| Sep 30, 2025 | -519.82% |
| Jun 30, 2025 | -1,035.90% |
| Mar 31, 2025 | -1,242.89% |
| Dec 31, 2024 | -1,082.13% |
| Sep 30, 2024 | -240.93% |
| Jun 30, 2024 | -464.71% |
| Mar 31, 2024 | -789.45% |
| Dec 31, 2023 | -23.03% |
| Sep 30, 2023 | -340.20% |
| Jun 30, 2023 | -1,702.25% |
| Mar 31, 2023 | -1,183.47% |
| Dec 31, 2022 | -375.07% |
| Sep 30, 2022 | -109.76% |
| Jun 30, 2022 | -1,373.95% |
| Mar 31, 2022 | -1,301.24% |
| Dec 31, 2021 | -1,525.18% |
Aclaris Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();